In hepatocellular carcinoma patients, the percentage and intensity of CD96 on NK cells, as well as the numbers of CD96+ NK cells, were higher in tumor-infiltrating NK cells compared with NK cells from peri-tumoral tissues [81]. The gene discussed is CD96; the disease is hepatocellular carcinoma.